| Enrollment Model Type | Coeff Tag | Year | Weight Score |
|---|---|---|---|
| CFA | HCC196 |
2026 | + 0.503 |
| CFD | HCC196 |
2026 | + 0.507 |
| CNA | HCC196 |
2026 | + 0.516 |
| CND | HCC196 |
2026 | + 0.642 |
| CPA | HCC196 |
2026 | + 0.427 |
| CPD | HCC196 |
2026 | + 0.248 |
| INS | HCC196 |
2026 | + 0.486 |
The following diagnoses map directly to HCC 196 under the V28 risk adjustment model:
| ICD-10 Code | Clinical Diagnosis Description | Guideline |
|---|---|---|
| G70.00 | Myasthenia gravis without (acute) exacerbation | Notes ↗ |
| G70.1 | Toxic myoneural disorders | Notes ↗ |
| G70.2 | Congenital and developmental myasthenia | Notes ↗ |
| G70.80 | Lambert-Eaton syndrome, unspecified | Notes ↗ |
| G70.81 | Lambert-Eaton syndrome in disease classified elsewhere | Notes ↗ |
| G70.89 | Other specified myoneural disorders | Notes ↗ |
| G70.9 | Myoneural disorder, unspecified | Notes ↗ |
| G73.1 | Lambert-Eaton syndrome in neoplastic disease | Notes ↗ |
| G73.3 | Myasthenic syndromes in other diseases classified elsewhere | Notes ↗ |